This actor was told he had Alzheimer's, now he's performing a one-man show
Context:
Diagnosed with Alzheimer’s two years ago, 85-year-old Peter Marinker is rehearsing a solo Beckett piece, Krapp’s Last Tape, for a London stage run in early September. A four-day production at the Cockpit Theatre will use intimate supports—an autocue, an on-set stage manager, and a discreet earpiece—together with archival recordings to enrich the performance. The project, led by director Dave Wybrow, aims to prove that collaborative, creative work can continue after a dementia diagnosis, with all profits going to the Alzheimer’s Society. The endeavor also highlights how memory in Alzheimer’s can be selective, preserving long-practised skills and scripts even as other memories fade, and it seeks to counter stigma around the condition. Marinker calls the venture his
Dive Deeper:
Peter Marinker, renowned for voice work and screen roles, was diagnosed with Alzheimer’s disease two years ago and has since been preparing for a solo stage performance of Krapp’s Last Tape in London. The plan emerged after a call from Dave Wybrow, director of the Cockpit Theatre, who wanted to give him time to rehearse and showcase the piece despite the diagnosis.
Rehearsals began at the end of June and include a full team: a stage manager beside the set, autocue screens around the theatre, and a tiny earpiece to prompt lines if needed. The production emphasizes collaboration rather than masking illness, illustrating that creative work can continue after a dementia diagnosis.
Marinker previously performed Krapp’s Last Tape in 1983, and the new production will weave in reel-to-reel recordings from that earlier performance to echo his younger self. The script is paired with memories and echoes from the older writer, blending past and present.
Experts note that memory loss in Alzheimer’s can be selective: certain long-term memories and well-rehearsed routines can remain accessible longer than new memories. This helps explain why Marinker can still perform a familiar script even as other memories fade.
All proceeds from the four-day run will go to the Alzheimer’s Society, which has highlighted that many people with dementia feel stigma and embarrassment about symptoms. The project is framed as a demonstration that people with dementia can still pursue meaningful passions and performances.
Marinker describes the venture as a ‘wonderful swan song,’ acknowledging the early stage of the disease while embracing the opportunity to stage the show and prepare for what lies ahead.